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Epilepsy is associated with excess mortality of two to three times in developed countries. Precise epidemiological data on mor-
tality and cause of death are not available from India or most other developing countries. This study was carried out to estimate
the mortality rates and to identify the demographic and clinical characteristics associated with mortality in a hospital based
cohort of epilepsy patients. A cohort of patients enrolled in the epilepsy clinic in 1985 was followed up till 1997 (12 years).
The mortality rate, demographic and clinical correlate of mortality were analysed for 246 patients (men 161, women 85) who
had complete data. Cause of death was not examined in this study. Eighteen (men 15, women 3) of the 246 patients (7.3%) had
died during the follow up period of 12 years. The crude death rate for the state of Kerala for the year 1990 (mid period of the
study) was 5.9 per thousand population. The demographic and clinical characteristics of those who died (corresponding figures
for survivors are given in brackets) were as follows: mean age 33.6 years (22.8 years), presence of abnormal neurological exam-
ination 38.9% (15.4%), mental retardation 33.3% (12.8%), abnormal CT scan 38% (21.5%). Regarding the seizure frequency
at the time of enrollment and eventual mortality, there were no deaths among patients who had an Engel’s seizure score of less
than or equal to 4 (no seizures or nocturnal seizures only). The mortality was 5% for an Engel’s score of 5 or 6 and 11% for
an Engel’s score greater than 6. Within the group with epilepsy, higher seizure frequency at the time of initial evaluation was
associated with excess mortality. Abnormality on neurological examination, older age group and male sex were other factors
that correlated with excess mortality.
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INTRODUCTION
Observations from developed countries indicate that
mortality is increased by two to three times among
people with epilepsy1–3. The excess mortality of
epilepsy, mostly at a premature age, constitutes con-
siderable economic burden to the society in terms
of quality adjusted life years that are lost. A recent
study indicates that mortality due to epilepsy is less
when seizures are controlled and greater excess when
seizures are not controlled4, although there are obser-
vations to the contrary too5. Data on the natural his-
tory and mortality of epilepsy from developing coun-
tries are sparse. Nearly 85% of the 40 million people
with epilepsy in the world live in developing countries.
Various infections of the CNS, and poor obstetric care
during birth contribute to the etiology in a larger pro-
portion of cases in these countries. ILAE and WHO
have estimated that there is a wide treatment gap in
developing countries, with the great majority not re-
ceiving any antiepileptic drug treatment6. Under these
circumstances mortality due to epilepsy is likely to
be higher in developing countries. A Medline search
did not show any publications on the mortality due to
epilepsy in developing countries. This study was car-
ried out to examine the mortality of epilepsy and to
identify the demographic and clinical characteristics
associated with mortality in India.
MATERIAL AND METHODS
Sree Chitra Tirunal Institute for Medical Sciences and
Technology, Trivandrum, Kerala State is a leading ter-
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tiary referral center for cardiac and neurological disor-
ders in South India. Over 8000 patients with epilepsy
are enrolled in the comprehensive epilepsy care center
attached to this institute. Those patients with epilepsy
who were enrolled in 1985 (n = 447) and followed
up until 1997 through the epilepsy program of this in-
stitute constituted the base population for this study.
All patients enrolled in 1985 (n = 447) were called
for review in the clinic in 1997. Patients who failed to
turn up at the clinic were sent two postal enquiries,
the last of which also enquired whether they were
alive. Altogether, 246 patients or their family members
reported in person or replied through letters. There
was no statistically significant difference in the de-
mographic or clinical characteristics between those
who were lost for follow up and those who main-
tained follow up. Family members of 18 patients re-
sponded to our enquiries by communicating the death
of the patient. Details of death were collected through
further enquiries with the family members wherever
possible. Clinical details regarding epilepsy were ex-
tracted from the medical records maintained in our in-
stitute. Seizure frequency was coded according to En-
gel’s score7, which scores the seizure count on a log-
arithmic scale ranging from 0 to 12. A score of less
than or equal to 4 indicates no seizures or only non-
disabling nocturnal or partial seizures. A score of 5 is
1–3 seizures per year, a score of 6 is 4–11 seizures
per year and scores of 7 and above refer to one or
more seizures per month. The crude death rate for the
middle (1990) of the follow up period (1985–97) for
Kerala State was taken as the reference death rate8.
The data was analysed using a SPSS plus statistical
package. Statistical significance of difference in group
means was calculated by a t-test and the difference in
proportions by a chi-squared test.
RESULTS
A total of 246 patients on whom data were available
formed the sample for this study. The median age for
the patients was 20 years, which was marginally lower
than that for the population of Kerala State (24.4 years)
for the year 1990. The epileptic syndromes for these
patients were classified as generalized epilepsy 87
(35.3%), localization related epilepsy 145 (58.9%) and
others 14 (5.7%). The relative proportion of various
epileptic syndromes identified among these patients
was comparable to that observed in a community-
based epidemiological study in the same state (gen-
eralized epilepsy 30.6%, localization related epilepsy
58.8%, others 10.6%)9. At the time of enrollment in
the study, the Engel’s score of seizure frequency was
less than 4 for 11 patients (4.5%), 5–6 for 139 patients
(57.2%) and 7 or greater for 93 patients (38.3%).
Table 1: Clinical and demographic characteristics of epilepsy
patients who had survived (n = 228) or expired (n = 18).
Characteristic Survivors (%) Expired (%) P
Age in years (mean ± SD) 22.8± 15.3 33.6± 25.5 0.09
Gender 0.09
Men 146 (90.7) 15 (9.3)
Women 82 (96.5) 3 (3.5)
Neurological exam
Normal 193 (94.6) 11 (5.4) 0.01
Abnormal 35 (83.3) 7 (16.7)
Mental retardation 29 (12.8) 6 (33.3) 0.02
Epilepsy classificationa
GE 80 (35.1) 7 (38.9) >0.1
LRE 134 (58.8) 11 (61.1)
Others 14 (6.1) —
Seizure frequency:
Engel’s score
1–4 11 (4.9) 0 (0) 0.09
5–6 132 (58.7) 7 (38.8)
7–12 82 (36.4) 11 (61.1)
CT scan (n = 117) >0.1
Normal 84 (78.5) 7 (70.0)
Abnormal 23 (21.5) 3 (30.0)
a GE = generalized epilepsy; LRE = localization related epilepsy.
During the study period of 12 years, 18 of the 246
patients (7.3%) had died. The crude mortality rate
for Kerala State for the year 1990 was 5.9 per 1000
population10. The clinical and demographic details of
those who survived are compared with those who died
in Table 1. Death rate was almost three times more
among men (9.3%) when compared to women (3.5%).
The mean age at the time of enrollment was higher
for those who expired (33.6 ± 25.5 years) than for
the survivors (22.8± 15.3 years). However, both these
trends did not achieve statistical significance. The fre-
quency of abnormal neurological findings or the pres-
ence of mental retardation was statistically signifi-
cantly higher among those who died (see Table 1).
With regard to the seizure frequency at the time of
enrollment and the risk of mortality, there were no
deaths among those who had an Engel’s score of 4 or
less (no seizures or non-disabling partial or nocturnal
seizures). The mortality was 5% for an Engel’s score
of 5 or 6 and 11% for an Engel’s score greater than 6.
There was no difference in the type of epilepsy be-
tween those who died and those who survived.
DISCUSSION
There are several methodological difficulties in es-
tablishing precise mortality statistics for epilepsy11.
Mortality is usually estimated by community surveys
and analysis of hospital data or public records like
death certificates. Each method has its own advantages
and limitations. Community surveys may be weak on
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the classification of epileptic syndrome and cause of
death. Analyses of autopsy data or death certificates
have their limitations because of difficulties in de-
termining the referent population and low recording
of epilepsy on death certificates12. Very few medi-
cal autopsies are carried out in developing countries.
The death certification in India until very recently had
been under the preview of the revenue department and
the cause of death is often not listed satisfactorily.
These limitations restrict the feasibility of community-
based studies on mortality due to epilepsy in India.
The base data for our study had certain advantages.
The patients were drawn from the community without
any economic, social or cultural bias. All age groups
were represented in this study, although the median
age was slightly younger (20 years) when compared
to the community (24 years) in Kerala State. Differ-
ent epileptic syndromes had the same representation
as in the community. There was good representation of
mild, moderate and severe epilepsy in terms of seizure
frequency and the follow up period was reasonably
long (maximum of 12 years).
This study gives the broad pattern of mortality for
people with epilepsy in India. It was found that 7.3%
of epilepsy patients in this study had died during the
12-year period. The crude death rate of this state (for
the mid-period of the study—1990) is 5.9 per 1000
population. Based on the annual crude death rate at
the mid-period of the study, the expected death rate of
Kerala over 12 years is approximately 70.8 per 1000
or 7.1% (5.9 times 12), which appears to be close
to the 7.3% observed for the patient cohort. How-
ever, there are several fallacies in concluding that the
death rates are comparable for both groups. Firstly, the
death rate for epilepsy is for a cohort followed up for
12 years, whereas that for the population is for one
calendar year (1990). Secondly, the epilepsy group is
slightly younger (median age 20 years) than the pop-
ulation (median age 24.4 years) in whom we would
expect a lower mortality in contrast to what was ob-
served. Infections, maternal and perinatal causes con-
stitute the majority of deaths (54.6%) in developing
countries, whereas they constitute only a small pro-
portion (9%) of deaths in developed countries13. It is
possible that the extent of mortality due to epilepsy
is overshadowed by high mortality due to infections,
maternal and perinatal causes. Standardized mortality
rates (SMR) could not be calculated as the precise date
of death was not available in most cases. Several com-
munity based as well as hospital based studies indicate
that mortality is increased by two to three times in peo-
ple with epilepsy1–3, 11, 12, 14. The mortality observed
in this cohort is comparable to that reported from an-
other tertiary care center in the UK15.
In this study, there was a clear preponderance for
more deaths among men (9.3%) than women (3.5%).
Most other studies have also observed that mortality is
higher for men than women1, 12, 14. The results reveal
that the mean age for the expired group was higher
(33.6 years) than that for the survivors (22.8 years),
although it did not reach statistical significance. Stud-
ies from the Netherlands reveal that mortality is higher
among those aged less than 20 years compared to those
above 20 years2. The excess mortality among children
may be reflecting the underlying neurological disor-
der or severity of epilepsy and relatively low mortality
among healthy children1.
Other factors that correlated with mortality in this
study were abnormal neurological examination, pres-
ence of mental retardation, and higher seizure fre-
quency. The presence of co-morbidities probably in-
dicates an underlying remote symptomatic cause for
epilepsy. Similar observations have been made in com-
munity based studies as well as hospital based stud-
ies from elsewhere. In this study there was no correla-
tion between the type of epilepsy and increased mor-
tality. Olafsson et al. noticed that the increased mor-
tality in epilepsy is primarily due to greater mortality
in patients with remote symptomatic seizures, whereas
the mortality for idiopathic unprovoked seizures was
not significantly increased16.
With regard to the severity of epilepsy, there were
no deaths among patients who were seizure free.
Mortality was increased as the frequency of seizures
increased. Previous studies have also indicated that
the relative risk of death increases with persistent
seizures1. In a study from the USA, the SMR for
patients with recurrent seizures was 4.69, whereas
among the patients who became seizure free, there was
no difference in mortality rate compared with the age
and sex matched population17. These observations in-
dicate that effective control of seizures would probably
reduce the mortality of epilepsy.
Cause of death was not explored in this study. Stud-
ies from developed countries have revealed that excess
mortality in a younger age group was due to remote
symptomatic causes while among an older age group
the causes were often accidental deaths including sui-
cide14. Sudden unexpected death constitutes a major
proportion of deaths among young people. No such
analysis was attempted in this study. It is recognized
that medical certification of cause of death is a poor
source of information in the case of epilepsy and other
chronic disorders with low case fatality rates. Epilepsy
may not be mentioned as the primary or secondary
cause of death in most cases. In this study, there is no
satisfactory certification of cause of death. Many of the
subjects had died outside formal medical services.
This study has highlighted the difficulties in eval-
uating mortality of epilepsy in a developing country.
Our salient observations were that the mortality pat-
tern for epilepsy in India is comparable to elsewhere,
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and that there is a correlation between the presence
of co-morbidities and poor control of seizures with
mortality for epilepsy. Further studies on the mortal-
ity of epilepsy in developing countries are essential to
improve epilepsy care and quality of life for people
with epilepsy.
REFERENCES
1. Tomson, T. Mortality in epilepsy. Journal of Neurology 2000;
247: 15–21.
2. Shackleton, D. P., Westendorp, R. G., Trenite, D. G. and Van-
denbroucke, J. P. Mortality in patients with epilepsy: 40 years
of follow up in a Dutch cohort study. Journal of Neurology,
Neurosurgery and Psychiatry 1999; 66: 636–640.
3. Cockerell, O. C. The mortality of epilepsy. Current Opinions
in Neurology 1996; 9: 93–96.
4. O’Callaghan, F. J., Osmond, C. and Martyn, C. N. Trends
in epilepsy mortality in England and Wales and the United
States 1950–1994. American Journal of Epidemiology 2000;
151: 182–189.
5. O’Donoghue, M. F. and Sander, J. W. A historical perspective
on the mortality associated with chronic epilepsy. Acta Neuro-
logica Scandinavica 1977; 96: 138–141.
6. Anonymous, Epilepsy in developing countries. Epilepsy out
of the shadows, Campaign information 7. Heemstede, The
Netherlands, ILAE, 1997.
7. Engel, J. Jr, Van Ness, P. C., Rasmussen, T. B. and Ojemann,
L. M. Outcome with respect to epileptic seizures. In: Surgical
Treatment of the Epilepsies (Ed. J. Engel Jr). New York, Raven
Press, 1993: pp. 609–622.
8. Zachariah, K. C., Rajan, S. I., Sarma, P. S., Navaneetham, K.
et al. Demographic Transition in Kerala in the 1980s. 2nd
Edition, Trivandrum, Center for Development Studies, 1994:
p. 40.
9. Radhakrishnan, K., Pandian, J. D., Santhoshkumar, T.,
Thomas, S. V. et al. Prevalence, knowledge, attitude and prac-
tice of epilepsy in Kerala, South India. Epilepsia 2000; 41:
1027–1035.
10. Registrar General, Census of India. Single year age re-
turns. New Delhi, 1991.
11. Nashef, L. and Shorvon, S. D. Mortality of Epilepsy. Epilepsia
1997; 38: 1059–1061.
12. Hauser, W. A. and Hesdorffer, D. C. The natural history
of seizures. In: The Treatment of Epilepsy: Principles and
Practice. 2nd Edition (Ed. E. Wyllie). Baltimore, Williams &
Wilkins, 1996: pp. 173–178.
13. Anonymous, Global estimates for health situation assess-
ment and projections 1990. Geneva, World Health Organiza-
tion, 1990: pp. 14–179.
14. Nilsson, L., Tomson, T., Farahmand, B. Y., Diwan, V. and
Persson, P. G. Cause specific mortality in epilepsy: a cohort
of more than 9000 patients once hospitalized for epilepsy.
Epilepsia 1997; 38: 1062–1068.
15. Nashef, L., Fish, D. R., Sander, J. W. and Shorvon, S. D. Inci-
dence of sudden unexpected death in an adult outpatient cohort
with epilepsy at a tertiary referral center. Journal of Neurology,
Neurosurgery and Psychiatry 1995; 58: 462–464.
16. Olafsson, E., Hauser, W. A. and Gudmundsson, G. Long-
term survival of people with unprovoked seizures: a population
based study. Epilepsia 1998; 39: 89–92.
17. Sperling, M. R., Feldman, H., Kinman, J., Liporace, J. D. and
O’Connor, M. J. Seizure control and mortality in epilepsy. An-
nals of Neurology 1999; 46: 45–50.
